Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
Michelle C. Williams(British Heart Foundation), Edward Nicol(Royal Brompton & Harefield NHS Foundation Trust), Amanda Hunter(Institute of Occupational Medicine), Tania Pawade(MACOM (United States)), Shirjel Alam(MACOM (United States)), Jonathan Weir‐McCall(St Thomas' Hospital), Alastair J. Moss(MACOM (United States)), Marc R. Dweck(British Heart Foundation), Anoop Shah(Imperial College Healthcare NHS Trust), Edwin J.R. van Beek(University of Edinburgh), Philip D Adamson(MACOM (United States)), David E. Newby(British Heart Foundation), Giles Roditi(NHS Greater Glasgow and Clyde)
Cited by 593
Related Papers
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure
|Particle and Fibre Toxicology|2005|929
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
Adverse cardiovascular effects of air pollution
|Nature Clinical Practice Cardiovascular Medicine|2008|778